Using a network to improve overdose education and naloxone access
Feasibility of Leveraging the National PulsePoint CPR Responder Network to Facilitate Overdose Education and Naloxone Distribution
This study is looking at how a community network can help teach people about opioid overdoses and make sure they have access to naloxone, a medication that can save lives, so that more folks are ready to help in an emergency.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Trustees of Indiana University NIH-funded |
| Lab location | 1 site (Bloomington, United States) |
| Project ID | NIH-10929501 on NIH RePORTER |
What this research studies
This research investigates how the National PulsePoint CPR Responder Network can be utilized to enhance overdose education and facilitate the distribution of naloxone, a life-saving medication that can reverse opioid overdoses. The project aims to train community members to respond effectively in overdose situations, ensuring that naloxone is readily available and that individuals are prepared to administer it when needed. By leveraging existing community resources and networks, the research seeks to create a more robust response system to the ongoing opioid crisis.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals living in communities affected by opioid overdoses, particularly those who may witness an overdose or have a loved one at risk.
Not a fit: Patients who do not reside in areas with high rates of opioid overdoses or who are not involved in community response efforts may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the number of fatal opioid overdoses by increasing access to naloxone and educating community members on its use.
How similar studies have performed: Previous research has demonstrated the effectiveness of overdose education and naloxone distribution programs in reducing fatal overdose rates, indicating that this approach has potential for success.
Where this research is happening
Bloomington, United States
- Trustees of Indiana University — Bloomington, United States (Active)
Researchers
- Principal investigator: Agley, Jon — Trustees of Indiana University
- Study coordinator: Agley, Jon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.